Florida Senate - 2009                                     SB 326
       
       
       
       By Senator Dean
       
       
       
       
       3-00394-09                                             2009326__
    1                        A bill to be entitled                      
    2         An act relating to optometry; amending s. 463.002,
    3         F.S.; revising definitions to conform to provisions
    4         authorizing the oral administration of ocular
    5         pharmaceutical agents by certain practitioners;
    6         amending s. 463.005, F.S.; requiring the Board of
    7         Optometry to adopt rules governing the administration
    8         and prescription of oral ocular pharmaceutical agents;
    9         amending s. 463.0055, F.S.; requiring an advisory
   10         committee to review requests for modifications of a
   11         formulary of topical and oral ocular pharmaceutical
   12         agents; requiring that the formulary consist of
   13         topical and oral pharmaceutical agents and those
   14         pharmaceutical agents appropriate to treat and
   15         diagnose ocular disease or disorders; requiring the
   16         prescriber number to be printed on a prescription for
   17         an oral ocular pharmaceutical agent; amending ss.
   18         463.0057 and 463.006, F.S., relating to faculty
   19         certificates and licensure and certification by
   20         examination; conforming provisions to changes made by
   21         the act; amending s. 893.02, F.S.; redefining the term
   22         “practitioner” for purposes of the Florida
   23         Comprehensive Drug Abuse Prevention and Control Act to
   24         include certified optometrists; amending s. 893.05,
   25         F.S.; prohibiting an optometrist from administering or
   26         prescribing certain controlled substances; providing
   27         an effective date.
   28         
   29  Be It Enacted by the Legislature of the State of Florida:
   30         
   31         Section 1. Subsections (3), (4), and (5) of section
   32  463.002, Florida Statutes, are amended to read:
   33         463.002 Definitions.—As used in this chapter, the term:
   34         (3)(a) “Licensed practitioner” means a person who is a
   35  primary health care provider licensed to engage in the practice
   36  of optometry under the authority of this chapter.
   37         (b) A licensed practitioner who is not a certified
   38  optometrist shall be required to display at her or his place of
   39  practice a sign that which states, “I am a Licensed
   40  Practitioner, not a Certified Optometrist, and I am not able to
   41  prescribe topical or oral ocular pharmaceutical agents.”
   42         (c) All practitioners initially licensed after July 1,
   43  1993, must be certified optometrists.
   44         (4) “Certified optometrist” means a licensed practitioner
   45  authorized by the board to administer and prescribe topical and
   46  oral ocular pharmaceutical agents.
   47         (5) “Optometry” means the diagnosis of conditions of the
   48  human eye and its appendages; the employment of any objective or
   49  subjective means or methods, including the administration of
   50  topical and oral ocular pharmaceutical agents, for the purpose
   51  of determining the refractive powers of the human eyes, or any
   52  visual, muscular, neurological, or anatomic anomalies of the
   53  human eyes and their appendages; and the prescribing and
   54  employment of lenses, prisms, frames, mountings, contact lenses,
   55  orthoptic exercises, light frequencies, and any other means or
   56  methods, including topical and oral ocular pharmaceutical
   57  agents, for the correction, remedy, or relief of any
   58  insufficiencies or abnormal conditions of the human eyes and
   59  their appendages.
   60         Section 2. Paragraph (g) of subsection (1) of section
   61  463.005, Florida Statutes, is amended to read:
   62         463.005 Authority of the board.—
   63         (1) The Board of Optometry has authority to adopt rules
   64  pursuant to ss. 120.536(1) and 120.54 to implement the
   65  provisions of this chapter conferring duties upon it. Such rules
   66  shall include, but not be limited to, rules relating to:
   67         (g) Administration and prescription of topical and oral
   68  ocular pharmaceutical agents.
   69         Section 3. Section 463.0055, Florida Statutes, is amended
   70  to read:
   71         463.0055 Administration and prescription of topical and
   72  oral ocular pharmaceutical agents; committee.—
   73         (1) Certified optometrists may administer and prescribe
   74  topical and oral ocular pharmaceutical agents as provided in
   75  this section for the diagnosis and treatment of ocular
   76  conditions of the human eye and its appendages without the use
   77  of surgery or other invasive techniques. However, a licensed
   78  practitioner who is not certified may use topically applied
   79  anesthetics solely for the purpose of glaucoma examinations, but
   80  is otherwise prohibited from administering or prescribing
   81  topical or oral ocular pharmaceutical agents.
   82         (2)(a) There is hereby created a committee composed of two
   83  optometrists licensed pursuant to this chapter, appointed by the
   84  Board of Optometry, two board-certified ophthalmologists
   85  licensed pursuant to chapter 458 or chapter 459, appointed by
   86  the Board of Medicine, and one additional person who holds with
   87  a doctorate degree in pharmacology and who is not licensed
   88  pursuant to chapter 458, chapter 459, or this chapter, appointed
   89  by the State Surgeon General. The committee shall review
   90  requests for additions to, deletions from, or modifications of a
   91  formulary of topical and oral ocular pharmaceutical agents for
   92  administration and prescription by certified optometrists and
   93  shall provide to the board advisory opinions and recommendations
   94  on such requests. The formulary shall consist of those topical
   95  and oral ocular pharmaceutical agents that which the certified
   96  optometrist is qualified to use in the practice of optometry and
   97  shall include those pharmaceutical agents appropriate to treat
   98  and diagnose ocular disease or disorders within the scope of
   99  optometric practice. The board shall establish, add to, delete
  100  from, or modify the formulary by rule. Notwithstanding any
  101  provision of chapter 120 to the contrary, the formulary rule
  102  shall become effective 60 days following from the date it is
  103  filed with the Secretary of State.
  104         (b) The formulary may be added to, deleted from, or
  105  modified according to the procedure described in paragraph (a).
  106  Any person who requests an addition, deletion, or modification
  107  of an authorized topical or oral ocular pharmaceutical agent has
  108  shall have the burden of proof to show cause why such addition,
  109  deletion, or modification should be made.
  110         (c) The State Surgeon General has shall have standing to
  111  challenge any rule or proposed rule of the board pursuant to s.
  112  120.56. In addition to challenges for any invalid exercise of
  113  delegated legislative authority, the administrative law judge,
  114  upon such a challenge by the State Surgeon General, may declare
  115  all or part of a rule or proposed rule invalid if it:
  116         1. Does not protect the public from any significant and
  117  discernible harm or damages;
  118         2. Unreasonably restricts competition or the availability
  119  of professional services in the state or in a significant part
  120  of the state; or
  121         3. Unnecessarily increases the cost of professional
  122  services without a corresponding or equivalent public benefit.
  123  However, the challenge of a rule or proposed rule does there
  124  shall not create be created a presumption of the existence of
  125  any of the conditions cited in this subsection in the event that
  126  the rule or proposed rule is challenged.
  127         (d) Upon adoption of the formulary required by this
  128  section, and upon each addition, deletion, or modification to
  129  the formulary, the board shall mail a copy of the amended
  130  formulary to each certified optometrist and to each pharmacy
  131  licensed by the state.
  132         (3) A certified optometrist shall be issued a prescriber
  133  number by the board. Any prescription written by a certified
  134  optometrist for a topical or oral ocular pharmaceutical agent
  135  pursuant to this section shall have the prescriber number
  136  printed thereon.
  137         Section 4. Subsection (3) of section 463.0057, Florida
  138  Statutes, is amended to read:
  139         463.0057 Optometric faculty certificate.—
  140         (3) The holder of a faculty certificate may engage in the
  141  practice of optometry as permitted by this section, but may not
  142  administer or prescribe topical or oral ocular pharmaceutical
  143  agents unless the certificateholder has satisfied the
  144  requirements of s. 463.006(1)(b)4. and 5.
  145         Section 5. Subsections (2) and (3) of section 463.006,
  146  Florida Statutes, are amended to read:
  147         463.006 Licensure and certification by examination.—
  148         (2) The examination shall consist of the appropriate
  149  subjects, including applicable state laws and rules and general
  150  and ocular pharmacology with emphasis on the topical and oral
  151  application and side effects of ocular pharmaceutical agents.
  152  The board may by rule substitute a national examination as part
  153  or all of the examination and may by rule offer a practical
  154  examination in addition to the written examination.
  155         (3) Each applicant who successfully passes the examination
  156  and otherwise meets the requirements of this chapter is entitled
  157  to be licensed as a practitioner and to be certified to
  158  administer and prescribe topical and oral ocular pharmaceutical
  159  agents in the diagnosis and treatment of ocular conditions.
  160         Section 6. Subsection (20) of section 893.02, Florida
  161  Statutes, is amended to read:
  162         893.02 Definitions.—The following words and phrases as used
  163  in this chapter shall have the following meanings, unless the
  164  context otherwise requires:
  165         (20) “Practitioner” means a physician licensed pursuant to
  166  chapter 458, a dentist licensed pursuant to chapter 466, a
  167  veterinarian licensed pursuant to chapter 474, an osteopathic
  168  physician licensed pursuant to chapter 459, a naturopath
  169  licensed pursuant to chapter 462, or a podiatric physician
  170  licensed pursuant to chapter 461, or an optometrist certified
  171  pursuant to chapter 463 to administer and prescribe topical and
  172  oral ocular pharmaceutical agents, if provided such practitioner
  173  holds a valid federal controlled substance registry number.
  174         Section 7. Subsection (1) of section 893.05, Florida
  175  Statutes, is amended to read:
  176         893.05 Practitioners and persons administering controlled
  177  substances in their absence.—
  178         (1) A practitioner, in good faith and in the course of his
  179  or her professional practice only, may prescribe, administer,
  180  dispense, mix, or otherwise prepare a controlled substance, or
  181  the practitioner may cause the same to be administered by a
  182  licensed nurse or an intern practitioner under his or her
  183  direction and supervision only. A veterinarian may so prescribe,
  184  administer, dispense, mix, or prepare a controlled substance for
  185  use on animals only, and may cause it to be administered by an
  186  assistant or orderly under the veterinarian's direction and
  187  supervision only. An optometrist certified pursuant to chapter
  188  463 to administer and prescribe topical and oral ocular
  189  pharmaceutical agents may not administer or prescribe any
  190  controlled substances listed in Schedule I or Schedule II of s.
  191  893.03.
  192         Section 8. This act shall take effect July 1, 2009.